Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
BACKGROUND: In 2008, Guinea-Bissau introduced artemether-lumefantrine for treatment of uncomplicated malaria. Previously, 3 times the standard dose of chloroquine, that was probably efficacious against Plasmodium falciparum with the resistance-associated chloroquine-resistance transporter (pfcrt) 7...
Main Authors: | Ursing, J, Kofoed, P, Rodrigues, A, Blessborn, D, Thoft-Nielsen, R, Björkman, A, Rombo, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Paracetamol <it>versus </it>placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial
by: Ursing Johan, et al.
Published: (2011-06-01) -
No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used.
by: Johan Ursing, et al.
Published: (2009-08-01) -
Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania.
by: Färnert, A, et al.
Published: (2012) -
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
by: Tarning, J, et al.
Published: (2009) -
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
by: Venkatesan, M, et al.
Published: (2014)